27391-34-0 Usage
Uses
Used in Pharmaceutical Synthesis:
2-Phenylindole-5-sulfonic acid serves as a key intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its chemical properties facilitate the creation of diverse medicinal compounds.
Used in Dye Production:
In the dye industry, 2-Phenylindole-5-sulfonic acid is utilized for the production of dyes, capitalizing on its aromatic nature to create a range of colorants for different applications, including textiles and other materials.
Used as a Reagent in Chemical Reactions:
2-Phenylindole-5-sulfonic acid functions as a reagent in various chemical reactions, aiding in the synthesis of complex organic compounds and facilitating specific chemical transformations.
Used as a Fluorescent Probe in Biochemical and Medical Research:
Leveraging its fluorescent properties, 2-Phenylindole-5-sulfonic acid is employed as a probe in biochemical and medical research, enabling the tracking and visualization of biological processes and molecules.
Used in the Development of New Materials and Technologies:
Due to its unique chemical and physical attributes, 2-Phenylindole-5-sulfonic acid holds potential in the innovation of new materials and technologies, with applications that may extend beyond the current scope of industrial use.
Check Digit Verification of cas no
The CAS Registry Mumber 27391-34-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,3,9 and 1 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 27391-34:
(7*2)+(6*7)+(5*3)+(4*9)+(3*1)+(2*3)+(1*4)=120
120 % 10 = 0
So 27391-34-0 is a valid CAS Registry Number.
27391-34-0Relevant academic research and scientific papers
BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF
-
Page/Page column 67, (2012/02/06)
The present invention provides compounds of formula (I); or pharmaceutically acceptable salts thereof, wherein the variables are defined as herein. The present invention provides a method for manufacturing the compounds of formula (I), their therapeutic u
Structure-activity relationships of 2-aryl-1H-indole inhibitors of the NorA efflux pump in Staphylococcus aureus
Ambrus, Joseph I.,Kelso, Michael J.,Bremner, John B.,Ball, Anthony R.,Casadei, Gabriele,Lewis, Kim
scheme or table, p. 4294 - 4297 (2009/04/06)
The synthesis of 22 2-aryl-1H-indoles, including 12 new compounds, has been achieved via Pd- or Rh-mediated methodologies, or selective electrophilic substitution. All three methods were based on elaborations from simple indole precursors. SAR studies on
